Evidence map›Paper›PMID 39078391›Full record

ArticleJournal of virology2024

Conserved cysteine residues in Kaposi's sarcoma herpesvirus ORF34 are necessary for viral production and viral pre-initiation complex formation.

Tadashi Watanabe, Aidan McGraw, Kedhar Narayan, Hasset Tibebe, Kazushi Kuriyama, Mayu Nishimura, Taisuke Izumi, Masahiro Fujimuro, Shinji Ohno

Abstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Genetic Diversity in theBiomolecules · 2025
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Tadashi WatanabeDepartment of Virology, Graduate School of Medicine, University of the Ryukyus, Nakagami, Japan.ORCID 0000-0002-2555-9375
Aidan McGrawDepartment of Biology, College of Arts & Sciences, American University, Washington, D.C., USA.
Kedhar NarayanDepartment of Biology, College of Arts & Sciences, American University, Washington, D.C., USA.ORCID 0009-0002-5522-7571
Hasset TibebeDepartment of Biology, College of Arts & Sciences, American University, Washington, D.C., USA.
Kazushi KuriyamaDepartment of Virology, Graduate School of Medicine, University of the Ryukyus, Nakagami, Japan.
Mayu NishimuraDepartment of Cell Biology, Kyoto Pharmaceutical University, Kyoto, Japan.
Taisuke IzumiDepartment of Biology, College of Arts & Sciences, American University, Washington, D.C., USA.ORCID 0000-0001-8193-0813
Masahiro FujimuroDepartment of Cell Biology, Kyoto Pharmaceutical University, Kyoto, Japan.ORCID 0000-0002-5165-0789
Shinji OhnoDepartment of Virology, Graduate School of Medicine, University of the Ryukyus, Nakagami, Japan.ORCID 0000-0001-5409-7547

Funding

SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
Role of canonical and non-canonical beta-catenin signaling in HIV-1 latencyR15AI172610 · NIAID · SAINT JOSEPH'S UNIVERSITY · PI Taisuke Izumi · 2022 to 2026
$885k
American University (AU)HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 7R15AI172610MEXT | Japan Society for the Promotion of Science (JSPS) JP19K07669MEXT | Japan Society for the Promotion of Science (JSPS) JP21K08509NIAID NIH HHS P30 AI117970NIAID NIH HHS R15 AI172610Takeda Science Foundation (TSF)University of the Ryukyus 20SP04102Yakult Honsha (Yakult)
6 · The paper itself

Abstract

Kaposi's sarcoma herpesvirus (KSHV) ORF34 plays a significant role as a component of the viral pre-initiation complex (vPIC), which is indispensable for late gene expression across beta- and gammaherpesviruses. Although the key role of ORF34 within the vPIC and its function as a hub protein have been recognized, further clarification regarding its specific contribution to vPIC functionality and interactions with other components is required. This study employed a deep learning algorithm-assisted structural model of ORF34, revealing highly conserved amino acid residues across human beta- and gammaherpesviruses localized in structured domains. Thus, we engineered ORF34 alanine-scanning mutants by substituting conserved residues with alanine. These mutants were evaluated for their ability to interact with other vPIC factors and restore viral production in cells harboring the ORF34-deficient KSHV-BAC. Our experimental results highlight the crucial role of the four cysteine residues conserved in ORF34: a tetrahedral arrangement consisting of a pair of C-X IMPORTANCE: The initiation of late gene transcription is universally conserved across the beta- and gammaherpesvirus families. This process employs a viral pre-initiation complex (vPIC), which is analogous to a cellular PIC. Although KSHV ORF34 is a critical factor for viral replication and is a component of the vPIC, the specifics of vPIC formation and the essential domains crucial for its function remain unclear. Structural predictions suggest that the four conserved cysteines (C170, C175, C256, and C259) form a tetrahedron that coordinates the metal cation. We investigated the role of these conserved amino acids in interactions with other vPIC components, late gene expression, and virus production to demonstrate for the first time that these cysteines are pivotal for such functions. This discovery not only deepens our comprehensive understanding of ORF34 and vPIC dynamics but also lays the groundwork for more detailed studies on herpesvirus replication mechanisms in future research.

Indexed as

CysteineHerpesvirus 8, HumanViral ProteinsVirus ReplicationAmino Acid SequenceConserved SequenceGene Expression Regulation, ViralHEK293 CellsHumansCysteineViral ProteinsGammaherpesvirinaehuman herpesvirusesKaposi's sarcoma herpesviruslytic infectionregulation of gene expression

Identifiers

PMID39078391
PMCPMC11334519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.